BioCentury
ARTICLE | Clinical News

Novasome lipid-vesicle oral vaccine consisting of the lipopolysaccharide of the killed Shigella flexneri 2a bacterium: IG's Novavax division will begin a Phase

May 30, 1995 7:00 AM UTC

IGI Inc. (IG), Buena, N.J. Product: Novasome lipid-vesicle oral vaccine consisting of the lipopolysaccharide of the killed Shigella flexneri 2a bacterium Indication: Shigella diarrhea Status: IG's Nov...